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A B S T R A C T
Recent advances in legislation have enabled nurses in the United Kingdom (UK) to become Nurse
Independent and Supplementary Prescribers (NISP). The NISP can assess, diagnose and independently
prescribe any licensed medicine within their area of competence. This change has meant the number of
nurse prescribers in disease speciﬁc areas has increased. This study set out to assess the number of
Epilepsy Specialist Nurses (ESNs) prescribing and the context in which they do so.
A draft questionnaire was developed and piloted with 10 ESNs. Minor changes to improve data
collection were made. In April 2009 all known ESNs were invited via letter to complete the questionnaire.
One month later a follow up reminder was mailed to all ESNs to encourage participation. Data was
analyzed using percentages and cross tabulation.
Completed questionnaires were returned by 29 nurse prescribers. Twenty ESNs were working as
independent nurse prescribers, 6 as supplementary nurse prescribers and 3 as both. Prescribing practice
demonstrated that 21 (72%) signed prescriptions, 28 (97%) made recommendations to other prescribers,
14 (48%) prescribed or amended ward/in patient drug prescriptions and 10 (34%) used clinical
management plans. The medications prescribed by ESNs included anti-epilepsy medication, folic acid,
vitamin K, anti-depressants, steroids, rescue medication and the contraceptive pill. Most ESNs wrote a
prescription for a new drug at least once a week whilst most nurses titrated medication daily.
Nurse prescribers held higher academic qualiﬁcations and had worked in the ﬁeld of epilepsy for
years. Epilepsy specialist nurse prescribing enabled a holistic approach to patient care. This paper
identiﬁed the need for ESNs to update annually and audit their prescribing practice.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Approximately 70% of people with epilepsy have the potential
to be seizure free with accurate diagnosis and optimal treatment.1
However only 52% are seizure free in the UK2 demonstrating an
18% treatment gap.3 Appropriate diagnosis and treatment helps to
minimize social and ﬁnancial deprivation, stigmatization, misun-
derstanding, and promotes independence and employability.4
Once diagnosed with epilepsy, management involves the prescrip-
tion of long-term treatment with anti-epilepsy medication and
regular monitoring. The authors suggest that appropriate and early
treatment can reduce the number of General Practitioner (GP)
consultations and reduce emergency admissions to secondary care
due to seizures or seizure related injury.* Corresponding author. Tel.: +44 01604 544926.
E-mail address: melesina.goodwin@ngh.nhs.uk (M. Goodwin).
1059-1311/$ – see front matter  2011 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2011.07.004The National Health Service Plan5 suggests that nurses can
improve patient care by undertaking a wider range of clinical tasks
including making and receiving direct referrals, admitting and
discharging patients, ordering investigations and diagnostic tests,
running clinics and prescribing drugs. Nurse prescribing in the UK
was introduced in 1992 with ‘The Medicinal Products. Prescribing
by Nurses Act’ (1992) that permitted nurses to prescribe a limited
range of drugs that included wound dressings and ointments. The
Crown Report6 had previously identiﬁed that nurse prescribers
would improve patient care through improved use of nurse time.
To become a non-medical prescriber the nurse has to have
worked in the ﬁeld in which they intend to prescribe for at least 12
months and undertake a designated prescribing course. Once
passed the prescribing qualiﬁcation enables the nurse to prescribe
within his/her own level of professional competence and expertise.
Those who do so have to demonstrate the appropriate legal and
professional requirements. Courses are approved by the Nursing
and Midwifery Council (NMC) and teach the principles of safe
prescribing practice. The course is between 3 and 6 months longvier Ltd. All rights reserved.
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medical practitioner. Once the course is completed the qualiﬁca-
tion has to be registered with the NMC before the nurse can
lawfully prescribe. Individual employers may set local require-
ments such as an individual drug formulary for each individual
nurse prescriber.
A new form of prescribing ‘supplementary prescribing’ for allied
health professionals was suggested in 1999.7 Supplementary
prescribing is ‘a voluntary prescribing partnership between an
independent prescriber (doctor) and a supplementary prescriber
(nurse or pharmacist, etc.) to implement a patient speciﬁc clinical
management plan (CMP)’.8 ‘A CMP is an agreed, deﬁned plan of
treatment for a named patient which sets the legal boundaries of
the medication and the parameters of prescribing responsibility for
the supplementary prescriber’.9 Supplementary prescribing allows
the nurse to prescribe all general sales list items, all prescription
only medicines, all controlled drugs, off label medicines and
unlicensed drugs following diagnosis by the doctor.9
The law changed again in May 2006 to allow nurses to
independently prescribe. A Nurse Independent Prescriber (NISP)
can assess, diagnose and independently prescribe any licensed
medicine within the nurse’s area of competence,10 including
controlled drugs and off label medications. In December 2009 the
law was amended once again to include unlicensed medications.11
A recent paper12 identiﬁes that between 2% and 3% of nurses in
the UK are qualiﬁed to prescribe medicines independently. Since
allowing nurses to assess, diagnose and independently prescribe,
the number of nurses prescribing in disease speciﬁc areas has
increased and encompasses specialist and consultant nurses,
perhaps reﬂecting the relevance of this change to advanced nurse
practice. This ﬁnding is supported by our study that demonstrates
18% of all ESNs are nurse prescribers.
However there is evidence that nurses do not prescribe, or
prescribe infrequently after gaining their prescribing qualiﬁca-
tion.13,14 Reasons identiﬁed in our research include lack of access
to prescribing budgets, the inability to prescribe immediately on
qualifying which can lead to loss of conﬁdence, lack of access to
medical notes, peer support and clinical supervision.
It is imperative that independent nurse prescribers are safe,
update regularly, and their practice is beneﬁcial to patient care.
This paper will review the role of epilepsy specialist nurses (ESNs)
as prescribers and the problems that ESNs have encountered in
their prescribing practice.
2. Methodology
The research group developed a draft questionnaire that was
piloted with 10 ESNs and feedback was obtained on its design and1
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Fig. 1. Year prescribingquestions. Comments enabled the researchers to make some minor
changes to formulate the ﬁnal draft. In April 2009 all known ESNs
were invited to participate via letter. The completed questionnaire
was returned. One month later a follow up reminder was mailed to
all ESNs to encourage participation.
The data was analyzed using percentages and cross tabulation.
Data analyzed was sub-divided into those that had a prescribing
qualiﬁcation and those that had not. The results presented in this
paper are based on 29 epilepsy specialist nurse prescribers who
held the prescribing qualiﬁcation.
3. Results
Postal questionnaires were sent to 218 nurses. There were 120
replies (55%). Twenty-nine ESNs had completed the prescribing
course. Of these, 20 ESNs were working as independent nurse
prescribers, 6 as supplementary nurse prescribers and 3 as both.
The results presented are based on these 29 (100%) nurse
prescribers.
The respondents were epilepsy specialist nurses or senior
nurses with a signiﬁcant epilepsy role component. Twelve (42%)
worked in the ﬁeld of adults with epilepsy, 7 (24%) in paediatrics,
and 10 (34%) within learning disabilities. Seven ESNs worked with
more than one group of patients. The majority of respondents had
been in their current post over 10 years with 5 years or longer
working in the ﬁeld of epilepsy (Fig. 1).
The respondents worked across services with 19 (66%)
employed in secondary care services, 2 (7%) in primary care
services and 4 (14%) employed across both primary and secondary
care. Three (10%) worked in tertiary services and 1 (3%) in the
private sector. The level of academic qualiﬁcation ranged from
registered nurse (RN) qualiﬁcation to masters degree (2 RN (7%), 5
epilepsy diploma (17%), 13 1st degree (45%), 9 masters degree
(31%)). Nurse prescribing practice demonstrated that 21 (72%)
signed prescriptions, 28 (97%) made recommendations to alter
medication to other prescribers, 14 (48%) prescribed or amended
ward/in-patient drug prescriptions and 10 (34%) used clinical
management plans.
A range of drugs were prescribed or recommended by ESNs and
included anti-epilepsy medication, folic acid, vitamin K, anti-
depressants, steroids, rescue medication, anti-psychotic drugs and
the contraceptive pill. ESNs would then write to the GP (28 (97%))
and/or the patient (24 (83%)) and use other internal documenta-
tion to record drug changes (Fig. 2).
Only 15 (52%) of the nurse prescribers were involved with
inpatient prescribing. Of these 12 (41%) would alter drug charts
and/or 16 (55%) would speak directly to the patient’s doctor to
recommend medication change.6
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Fig. 2. Medication prescribed by ESN.
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medicine over the telephone. When starting a new drug 16 (55%) of
ESNs did this over the telephone following a previous face to face
discussion with the patient. The majority of ESNs 26 (90%) would
recommend stopping a drug because of an adverse drug reaction
such as an allergic rash over the telephone. All the ESN’s would
then document drug changes made via letter to the General
Practitioner (GP) 25 (86%), in the patients hospital case notes 19
(66%) and 13 (45%) would copy the GP letter to the patient.
Fourteen (48%) of ESN’s had audit processes in place and
another 3 were intending to implement an audit into their
prescribing practice in the near future.
It is essential that nurses keep updated particularly with regard
to prescribing practice yet only 22 (76%) stated that they kept
updated. This was achieved in a variety of ways through medical
colleagues 15 (52%), meetings 20 (69%), peers 12 (41%), confer-
ences 9 (31%), representatives 7 (24%), literature 9 (31%), study
days 10 (34%) and in other ways 3 (10%).
Off label prescribing occurs when medications are prescribed
outside of their licence.15 This is likely to occur when prescribing
anti-epilepsy medication for children. Off label prescribing was
carried out independently by 8 (28%) of ESNs, supplementary
prescribing using a CMP by 12 (41%) ESNs and/or through direct
advise to the patients doctor 19 (53%). ESNs wrote a prescription
for a new drug or recommended starting a new drug at least once a
week whilst most ESNs titrated medication on a daily basis.
4. Discussion
This paper demonstrates that 18% of all UK epilepsy specialist
nurses are prescribing. The majority of nurse prescribers in our
study held an academic qualiﬁcation at ﬁrst degree or higher. The
majority of respondents had been in post over 10 years
demonstrating those ESNs undertaking the prescribing qualiﬁca-
tion are working at an advanced level.16,17
Enabling nurses to independently prescribe any licensed
medicine in the UK improves the service patients receive by
increasing patient access to medicines, and providing greater
choice whilst ensuring patient safety.10,18 Our study identiﬁed that
as well as prescribing anti-epilepsy drugs ESNs also recommended,
and occasionally prescribed, folic acid, vitamin K, anti-depressants,
anti-psychotics, the oral contraceptive pill, steroids and rescue
medication. Although a diverse range of medications, all are
relevant to the co-morbidities of people with epilepsy. Nurses
working within a deﬁned specialty are ‘very familiar with, and
knowledgeable about. . .’19 the medications they use.Disease speciﬁc telephone advice lines have increasingly become
part of specialist nursing services offering quick and relevant access
to expertise as well as improving continuity of care.20 The Nursing
Midwifery Council (NMC) guidelines15 state that in exceptional
circumstances when a medication has been previously prescribed
and where changes to dose are deemed necessary the use of a non
face-to-face medium may be used, as long as the prescriber has prior
knowledge of the patient/condition and has access to the patients’
record. This rapid access to specialist advice ensures prompt and
appropriate action leading to reduced demand on GP services,
accident and emergency departments and neurology appointments
and ensures patient satisfaction with services.21
Nurses are accountable for ensuring their knowledge and skills
are up-to-date in order to maintain competency and prescribe safely.
The NMC. . . recommends that appraisal of continuing professional
development needs should be conducted annually as part of the
nurses personal development review using competency frameworks
such as those developed by The National Prescribing Centre.22
Audit should be undertaken to demonstrate prescribing
safety.22 Our study did not identify whether ESN used the
competency framework or any other tool to monitor and evaluate
their prescribing practice. Auditing of prescribing practice was
conducted by a small number of ESN’s.
Most ESNs described being able to independently prescribe as
reﬂecting positively on patient care. Twenty (69%) felt it improved
patient care by
 Enabling a holistic approach
 Overcoming delayed access to medicines
 Responsive in a timely fashion
 Increased the nurses’ autonomy
5. Conclusion
This study conﬁrms that the majority of ESN prescribers hold
higher academic qualiﬁcations and have worked in the ﬁeld of
epilepsy for years. The researchers believe the number of ESNs
completing the prescribing course is likely to increase in future years.
The ability to undertake Independent and Supplementary
prescribing has extended the role of ESNs in the UK and allows
a holistic approach to epilepsy care improving access to services
and the management of epilepsy.
There is a need for all nurse prescribers to ensure their ongoing
competence to prescribe through continuing professional devel-
opment. It should be a target for all ESN prescribers to update
M. Goodwin et al. / Seizure 20 (2011) 754–757 757annually and to audit their prescribing practice to demonstrate
prescribing safety. Further research is required to assess patient
satisfaction with ESN prescribing practice.
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